Evidence supports ribavirin use in Crimean-Congo hemorrhagic fever

2024-11-1020141201-971210.1016/j.ijid.2014.08.0162-s2.0-84916879563http://dx.doi.org/10.1016/j.ijid.2014.08.016https://hdl.handle.net/20.500.14288/16079Infectious diseasesEvidence supports ribavirin use in Crimean-Congo hemorrhagic feverLetter1878-3511348023600064Q112917